Conagen Revenue and Competitors

Claim your profile

Boston, MA USA



Total Funding



Estimated Revenue & Valuation

  • Conagen's estimated annual revenue is currently $11.9M per year.(i)
  • Conagen's estimated revenue per employee is $155,000
  • Conagen's total funding is $30M.

Employee Data

  • Conagen has 77 Employees.(i)
  • Conagen grew their employee count by -5% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation

Conagen Inc. is a leader in the area of bio-manufacturing. We engineer live organisms to produce molecules that are essential to our well-beings. Scientists and Engineers at Conagen use the latest synthetic biology tools to design metabolic pathways, improve production organisms, optimize production procedures, and ensure the quality as well as safety of the final products. We focus on bio-production of high value ingredients for food, nutrition, pharmaceutical, and renewable material industries. Science and Innovation are the driving forces of our Mission. Conagen is a discovery-based company. We are passionate about understanding and engineering metabolic pathways. Our scientists are equipped with unprecedented systemic information on cellular metabolisms. New automation systems and novel fermentation technologies are being developed to advance our bio-manufacturing capabilities. We are well-positioned to provide solutions for our customers, and are dedicated to bringing better products to the world.



Total Funding


Number of Employees


Revenue (est)


Employee Growth %





Conagen News

3-Oct-18 - Next Generation, Non-GMO Natural Preservatives Developed By

BEDFORD, Mass., Oct. 3, 2018 /PRNewswire/ -- Conagen, an innovative biotechnology company announced today that it had a major

21-Sep-18 - PureCircle sues SweeGen over stevia patent

Baking Business reported SweeGen has an exclusive licensing arrangement with Conagen, which owns the patent. According to PureCircle's

19-Sep-18 - Stevia suppliers face off in patent lawsuit

According to the lawsuit, SweeGen has an exclusive license agreement with Conagen, which owns U.S. Patent No. 10,023,604 issued on July

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding